ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Holders of 5% or more of IMA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ImageneBio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 13G | 7.86%878.5K shares | New | Aug 4, 20251 filing | Aug 4, 2025 | SEC |
| Biotechnology Value Fund L P | 13G/A | 7.20%802.1K shares | −1.10 ppfrom 8.30% | Feb 14, 20252 filings | Nov 14, 2025 | SEC |
| OrbiMed Advisors LLC | 13D/A | 6.92%773.8K shares | −9.79 ppfrom 16.71% | Jun 18, 20252 filings | Jul 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on ImageneBio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:09 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 7.20%802.1K shares | −1.10 ppfrom 8.30% | Sep 30, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Blue Owl Capital Holdings LP | 13G/A | 4.84%540.9K shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 4, 20254:31 PM ET | Deep Track Capital, LPand 2 others | 13G | 7.86%878.5K shares | New | Jul 28, 2025 | SEC |
| Aug 4, 20254:29 PM ET | Deep Track Capital, LPand 2 others | 13G/A | 0.00%0 shares | −5.21 ppfrom 5.21%Below 5% | Jul 28, 2025 | SEC |
| Jul 30, 20259:28 PM ET | OrbiMed Advisors LLCand 3 others | 13D/A | 6.92%773.8K shares | −9.79 ppfrom 16.71% | Jul 25, 2025 | SEC |
| Jul 29, 20254:53 PM ET | Atlas Venture Fund X, L.P.and 8 others | 13D/A | 2.10%241.8K shares | –Below 5% | Jul 25, 2025 | SEC |
| Jul 28, 20252:16 PM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 1.90%220.8K shares | −6.60 ppfrom 8.50%Below 5% | Jul 25, 2025 | SEC |
| Jun 18, 20258:23 PM ET | OrbiMed Advisors LLCand 3 others | 13D/A | 16.71%8.01M shares | – | Jun 14, 2025 | SEC |
| Jun 16, 202512:21 PM ET | BML Investment Partners, L.P.and 1 other | 13D | 8.50%4.09M shares | +0.90 ppfrom 7.60% | Jun 16, 2025 | SEC |
| Feb 14, 20254:32 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.21%2.52M shares | New | Feb 7, 2025 | SEC |
| Feb 14, 20254:22 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 8.30%4.01M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202510:47 AM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 7.60%3.65M shares | 0.00 ppfrom 7.60% | Dec 31, 2024 | SEC |
| Feb 13, 20254:22 PM ET | Gilead Sciences, Inc. | 13G/A | 3.60%1.52M shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 31, 20243:44 PM ET | BML Investment Partners, L.P.and 1 other | 13G | 7.60%3.65M shares | New | Dec 23, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ImageneBio, Inc. shares.
No Form 144 notices for ImageneBio, Inc. are on file.